New Products

Ortho Clinical Diagnostics


VITROS® Anti-HIV 1+2 Assay

Ortho Clinical Diagnostics, a Johnson & Johnson Company, announces the availability in the U.S., Puerto Rico, and U.S. territories of a new diagnostic assay for the detection of antibodies to HIV types 1 and/or 2. The VITROS® Anti-HIV 1+2 assay can be run in a fully automated, random access format on the VITROS® ECi/ECiQ Immunodiagnostic System and will be available on the VITROS® 5600 Integrated and the VITROS® 3600 Immunodiagnostic Systems*, all with Intellicheck technology. Results are readily available in less than 50 minutes. This marks the first anti-HIV 1+2 test in the U.S. capable of being run in full random access at any time, with other tests, providing immediate result reporting upon test completion. *Product availability on the VITROS® 5600 Integrated and VITROS® 3600 Immunodiagnostic Systems subject to local regulatory requirements.

Booth No. 1215  


VITROS® HBsAg ES Assay

Ortho Clinical Diagnostics, a Johnson & Johnson Company, introduces the VITROS® HBsAg ES Assay in markets outside the U.S. for use on the VITROS® ECi/ECiQ Immunodiagnostic System. It will also be available on the VITROS® 5600 Integrated and VITROS® 3600 Immunodiagnostic Systems*. This next-generation HBsAg assay provides excellent sensitivity to wild-type HBsAg plus broad reactivity across the a-determinant region for HBsAg mutations. This enhanced performance, combined with proven VITROS® technologies, delivers sensitivity and specificity for both early detection blood donor screening and diagnostic populations <0.10IU/mL. *Product availability on the VITROS® 5600 Integrated and VITROS® 3600 Immunodiagnostic Systems subject to local regulatory requirements.

Booth No. 1215


VITROS® 3600 Immunodiagnostic System

Ortho Clinical Diagnostics, a Johnson & Johnson Company, introduces the VITROS® 3600 Immunodiagnostic System, a high-capacity immunoassay system for routine and specialty immunoassay testing using three proven VITROS® technologies. MicroWell, with proprietary Enhanced Chemiluminescence, Intellicheck, and MicroSensor technologies ensure high-quality results without compromising workflow. The broad menu includes cardiac, thyroid, metabolic, endocrine, anemia, oncology, prenatal, and infectious disease assays. Productivity is enhanced by using intelligent sample management to optimize and prioritize assay processing and is point-in-space automation-ready. Productivity is further optimized with the ability to replace reagents and consumables while operating. The VITROS® 3600 Immunodiagnostic System: integrity and productivity by design.

Booth No. 1215


VITROS® 5600 Integrated System

Ortho Clinical Diagnostics, a Johnson & Johnson Company, introduces the VITROS® 5600 Integrated System, a high-capacity system uniquely designed to integrate more than 120 immunoassay and clinical chemistry assays on one system. The system seamlessly integrates five proven VITROS® technologies to ensure high-quality results, no sample carryover, and no reagent carryover. It includes MicroSlide, MicroTip, MicroWell, Intellicheck, and MicroSensor technologies. The system introduces a sample-centered design to optimize productivity, eliminating the need to move samples on a track or create sample aliquots and is point-in-space automation-ready. It is easy-to-use with infrequent calibration and minimal maintenance. Integration by design.

Booth No. 1215

Philips


Magnotech Point-of-Care Technology*

Magnotech is a new immunoassay technology that uses magnetic nanoparticles to measure target molecules in blood and saliva samples. The capabilities of this multi-analyte measurement—including speed, ease-of-use, and accuracy—could bring complex in vitro diagnostic tests out of the laboratory into decentralized settings, including acute care settings, primary care settings, and at home. *In development.

Booth No. 3915

Pointe Scientific, Inc.


Homocysteine Liquid-Stable Reagent Set 

The Pointe Scientific homocysteine reagent is based on an enzyme cycling sequence to enhance its sensitivity. This two-part, liquid-stable product has been developed to provide ease-of-use and optimal calibration and on-board stability. Standardized to NIST SRM 1955, the reagent also provides excellent correlation with immunoassay and HPLC methods. The reagent is compatible with both serum and EDTA plasma samples. A three-level, liquid-stable homocysteine control set is available to verify results. Instrument applications are available for a variety of automated, general chemistry analyzers.

Booth No. 1943

Polymedco, Inc.


OC-Sensor Diana Automated iFOBT Analyzer

The OC-Sensor Diana is the new gold standard in iFOB testing. Capable of performing 280 tests per hour, this compact instrument is ideal for small workstations. It measures width 24.8" x depth 22" x height 22" and weighs 133 lbs. This immunoturbidimetric method offers superior assay performance and enhanced patient outcomes. The patientcollects one sample from one stool instead of three separate specimens. The sample is collected and closed by the patient and never reopened. The instrument measures closed sample collection devices, so the laboratory technician never comes in contact with sample. The novel collection device and personal packs result in increased patient compliance.

Booth No. 1843


PATHFAST® Rapid Whole-Blood Analyzer for Cardiac Testing*

The PATHFAST rapid point-of-care system uses chemiluminescent technology combined with a unique magtration separation method that allows this system to report highly accurate results comparable to large platform instruments. The PATHFAST system employs individual cartridge-based technology and uses whole-blood samples. The PATHFAST system can handle six samples in batch or random access mode and report results in 17 minutes. The PATHFAST analyzer and NTproBNP assay have been 510(k)-cleared by the FDA. Troponin I, CK-MB, myoglobin, and hsCRP are pending FDA clearance. Its compact platform includes computer, touch-screen and printer, measuring 14.7" x 22.4" x 20.0" (W x D x H). *Pending FDA clearance.

Booth No. 1843


PATHFAST® Rapid Whole-Blood Analyzer for Fertility Testing

The PATHFAST rapid point-of-care system uses chemiluminescent technology combined with a unique magtration separation method that allows this system to report highly accurate results comparable to large platform instruments. The PATHFAST system employs individual cartridge-based technology and uses whole-blood samples. The PATHFAST system can handle six samples in batch or random access mode and report results in 17 minutes. The PATHFAST analyzer has been 510(k)-cleared by the FDA. Beta hCG, LH, FSH, prolactin, testosterone, E2, and progesterone assays are pending FDA clearance. Its compact platform includes computer, touch-screen and printer, measuring 14.7" x 22.4" x 20.0" (W x D x H).

Booth No. 1843

Primera DX 


ICEPlex*

ICEPlex is a new, fully automated bench-top molecular testing platform for quantitative multiplex analysis of target nucleic acids. ICEPlex integrates PCR with capillary electrophoresis (CE) and is capable of detecting up to 30 targets in a single reaction. ICEPlex offers the lab throughput flexibility with interchangeable 24, 48 and 96 sample formats. Typical time to result is 4 hours. The system is easy-to-operate and routine maintenance is minimal. Intuitive software with a touch-screen user interface controls and monitors instrument functions and provides complete result reporting at the end of the run. *In development and for research use only.

Booth No. 3769

Radiometer America Inc.


AQT90 FLEX Immunoassay Analyzer*

The AQT90 FLEX incorporates Radiometer’s trusted technology in a compact, cartridge-based instrument. This acute-care analyzer offers a small footprint, rapid start-up, and fast measurement time, making it ideal for use in clinical areas. At the same time, full connectivity, electronic QC, and remote support ensure the core lab maintains control of the testing process. *Pending FDA clearance.

Booth No. 3404

Roche Diagnostics


cobas® TaqScreen MPX Test

The Roche cobas® TaqScreen MPX Test for use on the cobas s 201 system, utilizing Real-Time PCR technology, is designed to screen samples from living donors, including donors of whole blood, blood components, and organs. Packaged in ready-to use reagent cassettes and developed specifically for use on Roche’s cobas s 201 system, the cobas® TaqScreen MPX Test offers the ability to detect five targets in a single test: HIV-1 Group M; HIV-1 Group O; HIV-2; HCV; and HBV. One test. Five viral targets. cobas® TaqScreen MPX Test for NAT donor screening. One Vision. Many Possibilities. COBAS, COBAS S and TAQSCREEN are trademarks of Roche.

Booth No. 1331


LightCycler® MRSA Advanced Test*

Roche’s LightCycler® MRSA Advanced Test will bring our history of quality and excellence to bear on one of today’s most critical issues—reducing the transmission and infection rates of methicillin-resistant Staphylococcus aureus (MRSA). The LightCycler® Instrument is a proven platform that has repeatedly set the standard for real-time PCR, and the LightCycler® MRSA Advanced Test will remain true to that heritage. From HIV to HAI, Roche is your most experienced partner in molecular diagnostics. This product is not cleared or available for use in the U.S. *In development.

Booth No. 1331

  
Handheld Base Unit

The new Handheld Base Unit from Roche brings connectivity to the CoaguChek XS Plus System, enabling the capture and management of data with the RALS®-Plus Data Management System from Medical Automation Systems (MAS). The Handheld Base Unit supports bi-directional data transfer between the CoaguChek XS Plus and RALS-Plus systems, enabling you to capture, manage, and connect to essential patient, operator, and quality data anywhere, anytime.

Booth No. 1331


cobas 8000 Analyzer Series*

Roche brings next generation consolidation to the high-volume testing lab. The cobas® 8000 analyzer series is designed for labs processing more than 3 million clinical chemistry and immunoassay tests per year. Four individual modules—cobas c 701 and cobas c 502 chemistry modules, cobas ISE module, and the cobas e 602 immunoassay module—can be configured into 19 unique combinations. The peak throughput of the cobas 8000 analyzer series is designed to be up to 8,400 tests per hour with the maximum number of reagents on-board of 270. The cobas 8000 analyzer series will also share many of the same features as other cobas modular platform analyzers. COBAS, COBAS C, AND COBAS E are trademarks of Roche. *In development.

Booth No. 1331


cobas p 701 Post Analytical Unit*

The cobas p 701 post analytical unit, from Roche Diagnostics, provides automated storage and retrieval for up to 30,000 sample tubes in a compact footprint (17 linear ft.). The cobas p 701 is designed to connect directly to Roche automation and stores up to 400 samples per hour conveniently in a refrigerated environment. With integration to the LIS, add-on test requests will be immediately sent to the instrument for retrieval. Samples will also be automatically disposed after a designated period of time. The cobas p 701 post analytical unit is designed to streamline your work flow and manage the entire life cycle of a sample tube. COBAS P is a trademark of Roche. *In development.

Booth No. 1331


ACCU-Check Inform II with RALS® Plus Data Management System*

The new ACCU-CHEK® Inform II system is designed to enable wired and wireless connectivity to the RALS®-Plus data management system from Medical Automation Systems. RALS-Plus provides one simple POC solution to facilitate improved efficiencies, compliance and outcomes across the continuum of care. Together the ACCU-CHEK® Inform II system and RALS-Plus will help hospitals streamline POC testing while also helping them improve patient identification, reduce reporting errors, and manage operators anywhere, anytime. *Pending FDA clearance.

Booth No. 1331

Page Access: